Literature DB >> 3107463

Biological activity of analogs of guanine and guanosine against American Trypanosoma and Leishmania spp.

J L Avila, T Rojas, A Avila, M A Polegre, R K Robins.   

Abstract

The growth inhibitory effects of six guanine and guanosine analogs, 3-deazaguanine (compound 1); 3-deazaguanosine (compound 2); 6-aminoallopurinol (compound 3); 9-beta-xylofuranosyl guanine (compound 4); a ribosylated derivative of compound 3, 6-aminopyrazolo(3,4-d)pyrimidin-4-one (compound 5); and 5-aminoformycin B (compound 6), were tested against some pathogenic members of the family of American Trypanosomatidae. Compounds 1 and 2 were highly active against Trypanosoma cruzi, Trypanosoma rangeli, and American Leishmania spp. in in vitro culture forms. Both compounds also showed antiprotozoal activity in T. cruzi-infected mice, with the optimal dose being about 30 mg/kg of body weight per day given as 10 consecutive doses. Compound 3 was the most active compound in vitro, inhibiting all of the American Trypanosomatidae culture forms tested. It was also highly inhibitory in mice that were acutely infected with T. cruzi, with the optimal dose being about 10 mg/kg of body weight per day. Ribosylation of compound 3 resulted in a derivative that showed decreased inhibitory activity on Trypanosomatidae multiplication. Compound 6 was highly inhibitory of in vitro multiplication of American Leishmania and T. rangeli but had no effect on T. cruzi epimastigotes and on mice that were acutely infected with T. cruzi. Compound 4 showed only a slight effect on T. cruzi epimastigotes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107463      PMCID: PMC174749          DOI: 10.1128/AAC.31.3.447

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Inhibition of purine nucleotide biosynthesis by 3-deazaguanine, its nucleoside and 5'-nucleotide.

Authors:  D G Streeter; H H Koyama
Journal:  Biochem Pharmacol       Date:  1976-11-01       Impact factor: 5.858

2.  Synthesis of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid by a novel ring closure of imidazole precursors.

Authors:  P D Cook; R J Rousseau; A M Mian; P Dea; R B Meyer; R K Robins
Journal:  J Am Chem Soc       Date:  1976-03-17       Impact factor: 15.419

3.  A purine nucleoside hydrolase from Trypanosoma gambiense, purification and properties.

Authors:  G Schmidt; R D Walter; E Königk
Journal:  Tropenmed Parasitol       Date:  1975-03

4.  Trypanosoma cruzi: defined medium for continuous cultivation of virulent parasites.

Authors:  J L Avila; A Bretaña; M A Casanova; A Avila; F Rodríguez
Journal:  Exp Parasitol       Date:  1979-08       Impact factor: 2.011

5.  Effects of 8-azaguanine on the pathogenesis of experimental Chagas' disease.

Authors:  J P Shoemaker; R V Hoffman
Journal:  J Parasitol       Date:  1969-06       Impact factor: 1.276

6.  Trypanosoma cruzi: allopurinol in the treatment of mice with experimental acute Chagas disease.

Authors:  J L Avila; A Avila
Journal:  Exp Parasitol       Date:  1981-04       Impact factor: 2.011

7.  Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation.

Authors:  D J Nelson; S W LaFon; J V Tuttle; W H Miller; R L Miller; T A Krenitsky; G B Elion; R L Berens; J J Marr
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

8.  Purine metabolism in Trypanosoma cruzi.

Authors:  R L Berens; J J Marr; S W LaFon; D J Nelson
Journal:  Mol Biochem Parasitol       Date:  1981-07       Impact factor: 1.759

9.  Effect of allopurinol on different strains of Trypanosoma cruzi.

Authors:  J L Avila; A Avila; E Muñoz
Journal:  Am J Trop Med Hyg       Date:  1981-07       Impact factor: 2.345

10.  Purine metabolism in Leishmania donovani and Leishmania braziliensis.

Authors:  J J Marr; R L Berens; D J Nelson
Journal:  Biochim Biophys Acta       Date:  1978-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.